Condition: Fractures, Bone · Trauma Injury · Sponsor: Dartmouth-Hitchcock Medical Center
The purpose of this study is to determine whether an indocyanine green (ICG) fluorescence imaging system (cBPI) can be used to provide surgeons with information about bone health or bone blood flow. This will help surgeons better understand the healing potential of bone and relative risk of complication. This is important to help surgeons select the most appropriate treatment for severe traumatic injuries and infections.
This description comes directly from the study's public registry record.
Jon Mikael Anderson · 603-653-3306 · jon.mikael.anderson@hitchcock.org
Ida L Gitajn, MD · 603-650-5000 · ida.l.gitajn@hitchcock.org
Always discuss trial participation with your own doctor first.
| Dartmouth-Hitchcock Medical Center | Lebanon, New Hampshire, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06793644